TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Investor Investigation Over Possible Violations of Federal Securities Laws

  • If you purchased shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
Regeneron Pharmaceuticals Inc
Security
NASDAQ: REGN

Summary

August 8, 2014 (Shareholders Foundation) - An investigation on behalf of investors of Regeneron Pharmaceuticals Inc (NASDAQ:REGN shares over potential securities laws violations by Regeneron Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Regeneron Pharmaceuticals Inc concerning whether a series of statements by Regeneron Pharmaceuticals regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Regeneron Pharmaceuticals Inc reported that its annual Total Revenue rose from $445.82 million in 2011 to over $2.1 billion in 2013 and its Net Loss of $221.76 million in 2011 turned into a net Income of $424.36 million in 2013. Shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) grew from $34.10 per share in early 2011 to as high as $347.62 per share in February 2014.

On August 8, 2014, NASDAQ:REGN shares closed at $338.32 per share.

Start Monitoring Your Investments